Follow
Rashmi Bhakuni
Rashmi Bhakuni
Postdoctoral Researcher | Department of Dermatology | University of Washington School of Medicine
Verified email at uw.edu - Homepage
Title
Cited by
Cited by
Year
Learning of bimanual motor sequences in normal aging
R Bhakuni, PK Mutha
Frontiers in aging neuroscience 7, 76, 2015
232015
Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer?
PH Goff, R Bhakuni, T Pulliam, JH Lee, ET Hall, P Nghiem
Cancers 13 (14), 3415, 2021
152021
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
N Singh, R Bhakuni, D Chhabria, S Kirubakaran
BMC Research Notes 13, 1-9, 2020
142020
Design, synthesis, and docking studies of new Torin2 analogs as potential ATR/mTOR kinase inhibitors
A Shaik, R Bhakuni, S Kirubakaran
Molecules 23 (5), 992, 2018
122018
Characterization of SPK 98, a Torin2 analog, as ATR and mTOR dual kinase inhibitor
R Bhakuni, A Shaik, B Priya, S Kirubakaran
Bioorganic & Medicinal Chemistry Letters 30 (23), 127517, 2020
42020
Novel pyrazolo [4, 3-c] quinolin-3-one derivatives as PDE5A inhibitors
A Shaik, HK Agarwal, R Bhakuni, S Kirubakaran
Current Topics in Medicinal Chemistry 19 (4), 305-315, 2019
22019
An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action
TH Pulliam, R Bhakuni, S Jani, K Smythe, B Seaton, L Tachiki, ...
Journal of Investigative Dermatology 142 (10), 2839, 2022
12022
1018 A transcriptional signature shared by circulating cancer-specific CD8 T cells
S Jani, T Pulliam, N Kumar, A Jojic, R Bhakuni, E Newell, P Nghiem
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy
R Bhakuni, PH Goff, JH Lee, T Pulliam, S Tabachnick-Cherny, ...
Journal of Investigative Dermatology 142 (10), 2837, 2022
2022
848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy
R Bhakuni, P Goff, JH Lee, T Pulliam, S Tabachnick-Cherny, ...
Journal of Investigative Dermatology 142 (8), S147, 2022
2022
DNA Damage Response Inhibitors as Potentiators of Radiation and Immunogenicity in Merkel Cell Carcinoma
PH Goff, R Bhakuni, T Pulliam, S Tabachnick-Cherny, CD Morningstar, ...
International Journal of Radiation Oncology, Biology, Physics 111 (3), e247, 2021
2021
DNA Damage Response Inhibitors Potentiate Immunogenic Cell Death and Radiotherapy in Merkel Cell Carcinoma
P Goff, R Bhakuni, T Pulliam, R Rengan, P Nghiem
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 44 (10), S19-S19, 2021
2021
LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockade
R Bhakuni, P Goff, J Lee, T Pulliam, S Cherny, CD Morningstar, P Nghiem
Journal of Investigative Dermatology 141 (9), B28, 2021
2021
Characterization of SPK 98, an ATP-competitive inhibitor of ATR and mTOR
R Bhakuni, A Shaik, B Priya, S Kirubakaran
2019
Molecular Investigation of ATR and NFBD1 as therapeutic targets in cancer
R Bhakuni
Indian Institute of Technology Gandhinagar, 2019
2019
Evaluation of Maltose Binding Protein-Tagged hATR Kinase Domain Catalytic Activity with p53 Ser-15 Phosphorylation
R Bhakuni, A Shaik, S Kirubakaran
Biochemistry 57 (47), 6592-6603, 2018
2018
Expression and purification studies on ATM kinase
K Bhowmik, R Bhakuni, S Kirubakaran
2018
High MDC1 expression in cervical cancer cells can affect the chemo-and radiotherapeutic response as its depletion leads to increased cell death
N Singh, R Bhakuni, S Kirubakaran
Cancer Research 78 (13_Supplement), 772-772, 2018
2018
High MDC1 expression in cervical cancer cells can affect the chemo and radio-therapeutic response as it inhibition leads to increased cell death
N Singh, R Bhakuni, S Kirubakaran
2018
Evaluation of MBP tagged-hATR kinase domain catalytic activity with p53 Ser-15 phosphorylation
R Bhakuni, A Shaik, S Kirubakaran
American Chemical Society, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20